Benefit by design: Determining the ‘value’ of donor human milk and medical products derived from human milk in NICU

The use of donor human milk to provide therapeutic benefit to infants should only proceed where there is positive ‘value’. This can be determined through an assessment of the benefit and the known risks. The emergence of new products derived from human milk requires new value assessments. The known...

Full description

Saved in:
Bibliographic Details
Published in:Seminars in perinatology 2019-11, Vol.43 (7), p.151157-151157, Article 151157
Main Author: Hartmann, Ben T.
Format: Article
Language:English
Subjects:
Best practice
Bioethics
Donor Human Milk Banking
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The use of donor human milk to provide therapeutic benefit to infants should only proceed where there is positive ‘value’. This can be determined through an assessment of the benefit and the known risks. The emergence of new products derived from human milk requires new value assessments. The known hazards in human milk are modified by differences in the donor selection, processing methods and intended use and result in a unique risk assessment where any of these factors vary. The human source of the raw product requires high ethical standards in the design of these services with care taken to protect donors and recipients from harm. Any supplement to maternal milk should be provided cautiously to avoid displacement of maternal lactation.
ISSN:0146-0005
1558-075X
DOI:10.1053/j.semperi.2019.06.005